A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate‐1 risk myelodysplastic syndrome

Overview of attention for article published in Cancer (0008543X), September 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,839 followers.

A phase 2 randomized multicenter study of 2 extended ... [Cancer. 2011] - PubMed - NCBI: http://t.co/y5AODTSW

Extended dosing of Ezatiostat (GSTP-1) improves multilineage Myeloodysplastic Syndromes: http://t.co/qO2DsNiR

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.